Albertsons Companies (ACI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Jun, 2026Executive summary
Annual meeting scheduled for August 6, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote on key proposals before August 5, 2026.
Voting matters and shareholder proposals
Election of ten directors, all recommended by the board.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending February 27, 2027.
Advisory vote on executive compensation (say-on-pay) recommended for approval.
Proposal to amend Certificate of Incorporation to eliminate supermajority voting, recommended for approval.
Proposal to amend Certificate of Incorporation for officer exculpation, recommended for approval.
Stockholder proposal for a report on human rights policy and due diligence, board recommends voting against.
Board of directors and corporate governance
Ten nominees for board election, including Sharon Allen, Frank Bruno, Kim Fennebresque, Susan Morris, Brian Rice, Alan Schumacher, Brian Kevin Turner, Mary Elizabeth West, Scott Wille, and David Zinsner.
Latest events from Albertsons Companies
- Proxy covers director elections, governance reforms, and robust ESG and compensation practices.ACI
Proxy filing22 Jun 2026 - Proxy covers director elections, compensation, governance reforms, and ESG priorities.ACI
Proxy filing8 Jun 2026 - Q4 net loss from opioid settlement; digital sales up 16% and dividend raised 13%.ACI
Q4 202614 Apr 2026 - Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202510 Jan 2026 - Identical sales and digital growth lifted revenue, but margins narrowed amid ongoing investments.ACI
Q1 20269 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20267 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20267 Jan 2026 - Q4 delivered strong digital and pharmacy growth, but margin pressure tempers 2025 optimism.ACI
Q4 202519 Dec 2025 - Board recommends against all shareholder proposals; focus remains on digital growth and ESG impact.ACI
Proxy Filing1 Dec 2025